Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126056683 | 12605668 | 3 | F | 20160707 | 20160802 | 20160729 | 20160829 | EXP | JP-ROCHE-1794264 | ROCHE | 58.00 | YR | F | Y | 43.00000 | KG | 20160829 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126056683 | 12605668 | 1 | PS | XELODA | CAPECITABINE | 1 | Oral | ADMINISTERING FOR TWO WEEKS | Y | 20896 | 1500 | MG | TABLET | BID | |||||
| 126056683 | 12605668 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | Y | 125085 | 7.5 | MG/KG | QD | |||||||
| 126056683 | 12605668 | 3 | SS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous (not otherwise specified) | U | 63239 | ||||||||||
| 126056683 | 12605668 | 4 | SS | ELPLAT | OXALIPLATIN | 1 | Intravenous drip | U | 0 | 180 | MG | Q3W | |||||||
| 126056683 | 12605668 | 5 | C | PYDOXAL | PYRIDOXAL | 1 | Oral | 0 | 2 | DF | TABLET | TID | |||||||
| 126056683 | 12605668 | 6 | C | FEXOFENADINE HYDROCHLORIDE. | FEXOFENADINE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 126056683 | 12605668 | 7 | C | PLETAAL | CILOSTAZOL | 1 | Oral | REPORTED AS PLETAAL OD | 0 | 1 | DF | TABLET | BID | ||||||
| 126056683 | 12605668 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 1 | DF | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126056683 | 12605668 | 1 | Colon cancer |
| 126056683 | 12605668 | 2 | Colon cancer |
| 126056683 | 12605668 | 3 | Product used for unknown indication |
| 126056683 | 12605668 | 4 | Colon cancer |
| 126056683 | 12605668 | 5 | Prophylaxis |
| 126056683 | 12605668 | 6 | Allergy prophylaxis |
| 126056683 | 12605668 | 7 | Cerebrovascular accident prophylaxis |
| 126056683 | 12605668 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126056683 | 12605668 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126056683 | 12605668 | Papule | |
| 126056683 | 12605668 | Rash | |
| 126056683 | 12605668 | Retroperitoneal abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126056683 | 12605668 | 1 | 20160627 | 20160628 | 0 | |
| 126056683 | 12605668 | 2 | 20160627 | 20160627 | 0 | |
| 126056683 | 12605668 | 4 | 20160627 | 0 | ||
| 126056683 | 12605668 | 5 | 20160627 | 20160628 | 0 | |
| 126056683 | 12605668 | 6 | 20160627 | 20160628 | 0 | |
| 126056683 | 12605668 | 7 | 201604 | 0 | ||
| 126056683 | 12605668 | 8 | 201604 | 0 |